Skip to main content
. Author manuscript; available in PMC: 2015 May 21.
Published in final edited form as: J Subst Abuse Treat. 2012 Mar 8;44(1):115–119. doi: 10.1016/j.jsat.2012.01.010

Table 1.

Percentage of staff who indicated specific reasons why MMTP patients decline an evaluation or treatment for HCV infection or fail to appear for an HCV evaluation.

Reasons for declining HCV evaluation/treatment or for failing to appear for evaluation Staff perception of reason for declining HCV evaluation (n=70) % (n) Staff perception of reason for failure to appear for evaluation (n=67) % (n)
Do not believe that treatment works 21.4 (15) 25.4 (17)
No access to HCV treatment provider 21.4 (15) 12.0 (8)
Afraid of side effects 64.3 (45) 49.3 (33)
Do not like medical treatment 24.2 (17) 34.3 (23)
No insurance 30.0 (21) 26.9 (18)
Do not feel sick 47.1 (33) 40.3 (27)
Concerns about stigma 7.1 (5) 6.0 (4)
No car fare 24.3 (17) 28.5 (19)
Distance to medical care 15.7 (11) 14.9 (10)
Not enough time 10.0 (7) 9.0 (6)
Other 10.0 (7) 3.0 (2)